Cours Iqvia Holdings Inc Nyse
Actions
US74876Y1010
Recherche biotechnologique et médicale
CA 2024 * | 15,53 Md 14,18 Md | CA 2025 * | 16,68 Md 15,23 Md | Capitalisation | 42,75 Md 39,04 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 1,32 Md 1,21 Md | Résultat net 2025 * | 1,58 Md 1,45 Md | VE / CA 2024 * | 3,53 x |
Dette nette 2024 * | 12,06 Md 11,01 Md | Dette nette 2025 * | 11,62 Md 10,61 Md | VE / CA 2025 * | 3,26 x |
PER 2024 * |
32,2
x | PER 2025 * |
26,9
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 69,76% |
Dernier transcript sur Iqvia Holdings Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 01/08/20 |
James Berkshire
COO | Chief Operating Officer | 51 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 03/10/16 |
Colleen Goggins
BRD | Director/Board Member | 68 | 27/07/17 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md | |
-16,98% | 10,07 Md |